cbdMD (YCBD) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced virtually at 11:00 A.M. ET on March 30, 2026, with CEO/CFO Ronan Kennedy presiding.

• Shareholders could access meeting materials and submit questions online.

• Formal business was prioritized, followed by a Q&A session.

Board and executive committee updates

• Directors and executive officers in attendance were introduced, including board members and the Chief Accounting Officer.

• Brian Pearlman was appointed as Inspector of Elections.

Shareholder proposals

• Seven directors were nominated for election for terms expiring at the 2027 AGM.

• Ratification of Cherry Bekaert LLP as independent auditor for FY ending September 30, 2026.

• Approval sought for a reverse stock split at a ratio between 1-for-2 and 1-for-10.

• Proposals included approval for Series B and Series C Preferred stock issuances, both potentially dilutive.

• Approval for an equity line of credit (ELOC) with CMC Master Fund, LP.

• Approval of the 2025 Equity Compensation Plan.

• Proposal to allow adjournment of the meeting for further proxy solicitation if needed.